Circulating endothelial progenitor cells in patients with unstable angina: Association with systemic inflammation

European Heart Journal

Volumn 25, Issue 12, 2004, Pages 1003-1008

  George, Jacob ^a   Goldstein, Emil ^a   Abashidze, Soulico ^a   Deutsch, Varda ^a   Shmilovich, Haim ^a   Finkelstein, Ariel ^a   Herz, Itzhak ^a   Miller, Hylton ^a   Keren, Gad ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Angina pectoris; C reactive proteins; Endothelial progenitor cells; Endothelium; Inflammation

Indexed keywords

C REACTIVE PROTEIN; FIBRONECTIN;

ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CELL ADHESION; CELL ASSAY; CELL COUNT; COLONY FORMING UNIT; CONTROLLED STUDY; CORONARY BLOOD VESSEL; DRUG USE; ENDOTHELIUM CELL; EVALUATION; FOLLOW UP; HEART MUSCLE NECROSIS; HUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN IMMOBILIZATION; STABLE ANGINA PECTORIS; STEM CELL; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; UNSTABLE ANGINA PECTORIS;

ANGINA, UNSTABLE; CELL ADHESION; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MALE; MIDDLE AGED; STEM CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULITIS;

EID: 3042752502     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ehj.2004.03.026     Document Type: Article

References (20)

1. Glass C.K., Witztum J.L. Atherosclerosis. The road ahead. Cell. 104:2001;503-516
2. Libby P. Inflammation in atherosclerosis. Nature. 420:2002;868-874
3. Casscells W., Naghavi M., Willerson J.T. Vulnerable atherosclerotic plaque: a multifocal disease. Circulation. 107:2003;2072-2075
4. Asahara T., Murohara T., Sullivan A., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 275:1997;964-967
5. Hristov M., Erl W., Weber P.C. Endothelial progenitor cells: mobilization, differentiation, and homing. Arterioscler. Thromb. Vasc. Biol. 23:2003;1185-1189
6. Vasa M., Fichtlscherer S., Aicher A., et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ. Res. 89:2001;E1-E7
7. Hill J.M., Zalos G., Halcox J.P., et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N. Engl. J. Med. 348:2003;593-600
8. Tepper O.M., Galiano R.D., Capla J.M., et al. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation. 26(106):2002;2781-2786
9. Kalka C., Masuda H., Takahashi T., et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc. Natl. Acad. Sci. USA. 97:2000;3422-3427
10. Assmus B., Schachinger V., Teupe C., et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation. 106:2002;3009-3017
11. Rauscher F.M., Goldschmidt-Clermont P.J., Davis B.H., et al. Aging, progenitor cell exhaustion, and atherosclerosis. Circulation. 108:2003;457-463
12. Werner N., Junk S., Laufs U., et al. Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury. Circ. Res. 93:2003;e17-e24
13. Asahara T., Takahashi T., Masuda H., et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J. 18:1999;3964-3972
14. Shintani S., Murohara T., Ikeda H., et al. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation. 103:2001;2776-2779
15. Emond M., Mock M.B., Davis K.B., et al. Long-term survival of medically treated patients in the coronary artery surgery study (CASS) registry. Circulation. 90:1994;2645-2657
16. George J., Herz I., Goldstein E., et al. Number and adhesive properties of circulating endothelial progenitor cells in patients with in-stent restenosis. Arterioscler. Thromb. Vasc. Biol. 23:2003;e57-e60
17. Llevadot J., Murasawa S., Kureishi Y., et al. HMG-CoA reductase inhibitor mobilizes bone marrow-derived endothelial progenitor cells. J. Clin. Invest. 108:2001;399-405
18. Ridker P.M. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation. 107:2003;363-369
19. Yeh E.T., Willerson J.T. Coming of age of C-reactive protein: using inflammation markers in cardiology. Circulation. 107:2003;370-371
20. Heeschen C., Aicher A., Lehmann R., et al. Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. Blood. 102:2003;1340-1346